BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18607065)

  • 1. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
    Hess CJ; Ameziane N; Schuurhuis GJ; Errami A; Denkers F; Kaspers GJ; Cloos J; Joenje H; Reinhardt D; Ossenkoppele GJ; Zwaan CM; Waisfisz Q
    Cell Oncol; 2008; 30(4):299-306. PubMed ID: 18607065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia.
    Meyer S; White DJ; Will AM; Eden T; Sim A; Brown R; Strathdee G
    Br J Haematol; 2006 Jul; 134(1):61-3. PubMed ID: 16803569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia.
    Barber LM; McGrath HE; Meyer S; Will AM; Birch JM; Eden OB; Taylor GM
    Br J Haematol; 2003 Apr; 121(1):57-62. PubMed ID: 12670332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the FA/BRCA pathway in bladder cancer.
    Neveling K; Kalb R; Florl AR; Herterich S; Friedl R; Hoehn H; Hader C; Hartmann FH; Nanda I; Steinlein C; Schmid M; Tonnies H; Hurst CD; Knowles MA; Hanenberg H; Schulz WA; Schindler D
    Cytogenet Genome Res; 2007; 118(2-4):166-76. PubMed ID: 18000367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.
    Tischkowitz M; Ameziane N; Waisfisz Q; De Winter JP; Harris R; Taniguchi T; D'Andrea A; Hodgson SV; Mathew CG; Joenje H
    Br J Haematol; 2003 Nov; 123(3):469-71. PubMed ID: 14617007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Fanconi anaemia genes FANCA, FANCC and FANCL in cervical cancer susceptibility.
    Juko-Pecirep I; Ivansson EL; Gyllensten UB
    Gynecol Oncol; 2011 Aug; 122(2):377-81. PubMed ID: 21543111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
    Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
    Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.
    Szaumkessel M; Richter J; Giefing M; Jarmuz M; Kiwerska K; Tönnies H; Grenman R; Heidemann S; Szyfter K; Siebert R
    Int J Oncol; 2011 Aug; 39(2):505-14. PubMed ID: 21567085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.
    Zhang J; Wang X; Lin CJ; Couch FJ; Fei P
    Cancer Biol Ther; 2006 Dec; 5(12):1632-6. PubMed ID: 17106252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.
    Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
    Biochem J; 2012 Nov; 448(1):153-63. PubMed ID: 22873408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
    Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
    Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.
    Narayan G; Arias-Pulido H; Nandula SV; Basso K; Sugirtharaj DD; Vargas H; Mansukhani M; Villella J; Meyer L; Schneider A; Gissmann L; Dürst M; Pothuri B; Murty VV
    Cancer Res; 2004 May; 64(9):2994-7. PubMed ID: 15126331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
    Ali AM; Kirby M; Jansen M; Lach FP; Schulte J; Singh TR; Batish SD; Auerbach AD; Williams DA; Meetei AR
    Hum Mutat; 2009 Jul; 30(7):E761-70. PubMed ID: 19405097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
    Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
    Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
    Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
    Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
    van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
    Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.